scholarly article | Q13442814 |
P50 | author | Achilleas Floudas | Q88313635 |
Luke A. J. O'Neill | Q24209151 | ||
Andrew N. J. McKenzie | Q30106734 | ||
Christian Schwartz | Q57090701 | ||
Graham Ogg | Q60327610 | ||
Gabriel Núñez | Q63409996 | ||
Alan D. Irvine | Q39066910 | ||
Padraic G. Fallon | Q42944857 | ||
Jocelyne Demengeot | Q47410059 | ||
Sean P. Saunders | Q55948319 | ||
Patrick T Walsh | Q56246146 | ||
Yoichiro Iwakura | Q56564114 | ||
P2093 | author name string | Joana Bom | |
Tara Moran | |||
Agnieszka Kaszlikowska | |||
P2860 | cites work | Genetic variation determines mast cell functions in experimental asthma | Q84102352 |
Cytokine modulation of atopic dermatitis filaggrin skin expression | Q84498043 | ||
Atopic dermatitis | Q86174273 | ||
Dupilumab treatment in adults with moderate-to-severe atopic dermatitis | Q87371931 | ||
Dupilumab: A review of its use in the treatment of atopic dermatitis | Q87853471 | ||
Extracellular Neutrophil Proteases Are Efficient Regulators of IL-1, IL-33, and IL-36 Cytokine Activity but Poor Effectors of Microbial Killing | Q88055796 | ||
Key component of inflammasome, NLRC4, was identified in the lesional epidermis of psoriatic patients | Q88804115 | ||
Injury, dysbiosis, and filaggrin deficiency drive skin inflammation through keratinocyte IL-1α release | Q91626434 | ||
Rapid and specific conversion of precursor interleukin 1 beta (IL-1 beta) to an active IL-1 species by human mast cell chymase | Q24336387 | ||
Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity | Q24630261 | ||
Topographical and temporal diversity of the human skin microbiome | Q24647583 | ||
Gout-associated uric acid crystals activate the NALP3 inflammasome | Q28131797 | ||
Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis | Q28255158 | ||
Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis | Q28259055 | ||
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf | Q28266417 | ||
Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis | Q28303063 | ||
Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo | Q28506160 | ||
Tmem79/Matt is the matted mouse gene and is a predisposing gene for atopic dermatitis in human subjects | Q28511427 | ||
RAG-1-deficient mice have no mature B and T lymphocytes | Q28592133 | ||
The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses | Q29614469 | ||
Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells | Q30612542 | ||
A two-step process for cytokine production revealed by IL-4 dual-reporter mice | Q33677827 | ||
IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells | Q33869215 | ||
Eosinophils increase neuron branching in human and murine skin and in vitro. | Q33979626 | ||
MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion | Q34106637 | ||
Basophils promote innate lymphoid cell responses in inflamed skin | Q34218677 | ||
Filaggrin mutations associated with skin and allergic diseases. | Q34223419 | ||
An in vitro culture model to study the dynamics of colonic microbiota in Syrian golden hamsters and their susceptibility to infection with Clostridium difficile | Q35002637 | ||
Analyzing mast cell development and function using mice carrying mutations at W/c-kit or Sl/MGF (SCF) loci | Q35155640 | ||
Mast cell secretory granules: armed for battle | Q35182662 | ||
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. | Q35350543 | ||
Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity | Q35660131 | ||
Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice | Q35975739 | ||
IL-13 induces skin fibrosis in atopic dermatitis by thymic stromal lymphopoietin. | Q36102435 | ||
Impaired Tight Junctions in Atopic Dermatitis Skin and in a Skin-Equivalent Model Treated with Interleukin-17. | Q36121354 | ||
Critical role for mast cells in interleukin-1β-driven skin inflammation associated with an activating mutation in the nlrp3 protein | Q36137849 | ||
Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation | Q36291657 | ||
Production of mice deficient in genes for interleukin (IL)-1alpha, IL-1beta, IL-1alpha/beta, and IL-1 receptor antagonist shows that IL-1beta is crucial in turpentine-induced fever development and glucocorticoid secretion | Q36400734 | ||
Spontaneous atopic dermatitis is mediated by innate immunity, with the secondary lung inflammation of the atopic march requiring adaptive immunity | Q36526371 | ||
Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages | Q36694157 | ||
Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency. | Q36770768 | ||
TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation | Q36798825 | ||
The prevalence of mutations in the gene encoding filaggrin in the population of Polish patients with atopic dermatitis | Q36946174 | ||
Evidence of innate lymphoid cell redundancy in humans | Q37357543 | ||
A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. | Q37397800 | ||
IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation | Q37397810 | ||
TH9 cells that express the transcription factor PU.1 drive T cell–mediated colitis via IL-9 receptor signaling in intestinal epithelial cells | Q56671802 | ||
Possible Pathogenic Role of Th17 Cells for Atopic Dermatitis | Q56772998 | ||
Dupilumab progressively improves systemic and cutaneous abnormalities in atopic dermatitis patients | Q56889179 | ||
Systemic and stratum corneum biomarkers of severity in infant atopic dermatitis include markers of innate and T helper cell-related immunity and angiogenesis | Q57167945 | ||
IL-17A as an Inducer for Th2 Immune Responses in Murine Atopic Dermatitis Models | Q62735563 | ||
Tissue signals imprint ILC2 identity with anticipatory function. | Q64969347 | ||
Mast cells in atopic dermatitis | Q69802044 | ||
An obligate role for T-cell receptor alphabeta+ T cells but not T-cell receptor gammadelta+ T cells, B cells, or CD40/CD40L interactions in a mouse model of atopic dermatitis | Q73431465 | ||
Phenotypic and functional characterization of mice that lack the type I receptor for IL-1 | Q73748033 | ||
In activated mast cells, IL-1 up-regulates the production of several Th2-related cytokines including IL-9 | Q73812151 | ||
A distinct role for interleukin-13 in Th2-cell-mediated immune responses | Q74344715 | ||
Tissue eosinophilia in acute and chronic atopic dermatitis: a morphometric approach using quantitative image analysis of immunostaining | Q77331786 | ||
Severe atherosclerosis and hypoalphalipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor RORalpha | Q77677370 | ||
Persistent central memory phenotype of circulating Fel d 1 peptide/DRB1*0101 tetramer-binding CD4+ T cells | Q79396285 | ||
Fate mapping reveals separate origins of T cells and myeloid lineages in the thymus | Q83371591 | ||
Cellular and molecular mechanisms in atopic dermatitis | Q37499326 | ||
Skin microbiome before development of atopic dermatitis: Early colonization with commensal staphylococci at 2 months is associated with a lower risk of atopic dermatitis at 1 year | Q37552637 | ||
Filaggrin Mutation in Korean Patients with Atopic Dermatitis. | Q37622167 | ||
Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis | Q37709681 | ||
Inflammasome-independent regulation of IL-1-family cytokines | Q38286016 | ||
The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies | Q38733182 | ||
The Role of the Skin Microbiome in Atopic Dermatitis: A Systematic Review | Q38756577 | ||
Atopic dermatitis phenotypes and the need for personalized medicine | Q39352185 | ||
The interplay between genetic and environmental factors in the pathogenesis of atopic dermatitis. | Q39402846 | ||
IL-36α expression is elevated in ulcerative colitis and promotes colonic inflammation. | Q40058815 | ||
ILC2s regulate adaptive Th2 cell functions via PD-L1 checkpoint control. | Q40118341 | ||
IL-17 Receptor A Maintains and Protects the Skin Barrier To Prevent Allergic Skin Inflammation. | Q40172237 | ||
A mouse model for the human pathogen Salmonella typhi | Q40346083 | ||
Opposing functions of thymic stromal lymphopoietin-responsive basophils and dendritic cells in a mouse model of atopic dermatitis. | Q40627439 | ||
Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1beta | Q41457693 | ||
Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis | Q41719738 | ||
TH2 cytokines increase kallikrein 7 expression and function in patients with atopic dermatitis. | Q41877936 | ||
Type 2 helper T-cell cytokines induce morphologic and molecular characteristics of atopic dermatitis in human skin equivalent | Q42010436 | ||
Transgenic expression of interleukin-13 in the skin induces a pruritic dermatitis and skin remodeling | Q43183078 | ||
Mutations analysis in filaggrin gene in northern China patients with atopic dermatitis | Q43567219 | ||
Association of single nucleotide polymorphisms of interleukin-1 family with atopic dermatitis. | Q43592353 | ||
Defective NK cell activity and Th1 response in IL-18-deficient mice | Q43595287 | ||
Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses | Q44158655 | ||
The microbiota is important for IL-17A expression and neutrophil infiltration in lesional skin of Flg(ft/ft) mice | Q46799597 | ||
Expression of IL-22 in the Skin Causes Th2-Biased Immunity, Epidermal Barrier Dysfunction, and Pruritus via Stimulating Epithelial Th2 Cytokines and the GRP Pathway | Q48205671 | ||
IL-1β induces thymic stromal lymphopoietin and an atopic dermatitis-like phenotype in reconstructed healthy human epidermis | Q48247956 | ||
Divergent Roles of Interferon-γ and Innate Lymphoid Cells in Innate and Adaptive Immune Cell-Mediated Intestinal Inflammation. | Q49205651 | ||
The human skin microbiome | Q50051002 | ||
Early-onset pediatric atopic dermatitis is TH2 but also TH17 polarized in skin. | Q51459379 | ||
Dupilumab for Moderate-to-Severe Atopic Dermatitis. | Q51791317 | ||
Skin homing (cutaneous lymphocyte-associated antigen-positive) CD8+ T cells respond to superantigen and contribute to eosinophilia and IgE production in atopic dermatitis. | Q52033316 | ||
Of Mouse Models of Mast Cell Deficiency and Metabolic Syndrome. | Q52859997 | ||
Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. | Q54319446 | ||
P433 | issue | 10 | |
P921 | main subject | atopic dermatitis | Q268667 |
P304 | page(s) | 1920-1933 | |
P577 | publication date | 2019-04-29 | |
P1433 | published in | Allergy | Q2699825 |
P1476 | title | Spontaneous atopic dermatitis in mice with a defective skin barrier is independent of ILC2 and mediated by IL-1β | |
P478 | volume | 74 |